Waters Corporation Net Profit Margin

Net Profit Margin of WAT for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Profit Margin growth rates and interactive chart.


Highlights and Quick Summary

  • Net Profit Margin for the quarter ending December 30, 2020 was 27.75% (a 29.98% increase compared to previous quarter)
  • Year-over-year quarterly Net Profit Margin increased by 140.89%
  • Annual Net Profit Margin for 2020 was 22.05% (a -10.4% decrease from previous year)
  • Annual Net Profit Margin for 2019 was 24.61% (a 0.29% increase from previous year)
  • Annual Net Profit Margin for 2018 was 24.54% (a 2688.64% increase from previous year)
  • Twelve month Net Profit Margin ending December 30, 2020 was 22.05% (a 0.41% increase compared to previous quarter)
  • Twelve month trailing Net Profit Margin decreased by -3.16% year-over-year
Trailing Net Profit Margin for the last four month:
30 Dec '20 29 Sep '20 29 Jun '20 30 Mar '20
22.05% 21.96% 22.62% 22.77%
Visit stockrow.com/WAT for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Profit Margin of Waters Corporation

Most recent Net Profit Marginof WAT including historical data for past 10 years.

Interactive Chart of Net Profit Margin of Waters Corporation

Waters Corporation Net Profit Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 27.75% 21.35% 23.64% 11.52% 22.05%
2019 28.01% 23.93% 24.1% 21.21% 24.61%
2018 25.89% 24.4% 26.11% 21.1% 24.54%
2017 -51.39% 24.06% 23.61% 21.2% 0.88%
2016 27.73% 23.7% 23.9% 19.79% 24.06%
2015 25.75% 23.23% 21.36% 20.86% 22.97%
2014 25.91% 23.01% 20.04% 16.33% 21.7%
2013 25.04% 21.44% 19.8% 28.13% 23.63%
2012 33.72% 22.03% 21.65% 21.09% 25.03%
2011 26.3% 22.28% 22.36% 22.1% 23.39%
2010 26.18% 23.62% 21.72% 23.23%

Business Profile of Waters Corporation

Sector: Healthcare
Industry: Diagnostics & Research
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.